From: Individualized markers optimize class prediction of microarray data
Cross Reference Method | Our Method | |||||||
---|---|---|---|---|---|---|---|---|
Data Set | Performance | Selection/Classification | Performance | Sensitivity | Specificity | Common genes | ||
 | CV | Test |  | CV | Test |  |  |  |
AML/ALL | - | 29/34 | S2N/NA | - | 33/34 | 90.9% | 100% | 48/50 |
Breast Cancer | 47/49 | 5/5* | CC/FA | 48/49 | 5/5* | 100%* | 100%* | 81/100 |
Lung Cancer | - | 148/149 | 2-tail T/ER | - | 148/149 | 93.3% | 100% | 8/8 |
AML/MLL/ALL | 54/57 | 14/15 | CC/K-NN | 56/5 | 4/4, 3/3, 8/8 | - | - | 14/45 |
CNS | 47/60 | - | S2N/K-NN | 55/60 | - | 85.7% | 94.9% | 22/100 |
Lymph Node | 31/34 | - | CC/FA | 31/34 | - | 83.3% | 95.4% | N/A |